Empowered Funds
IRD icon

Empowered Funds’s Opus Genetics IRD Stock Holding History

Empowered Funds’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Hold
42,065
– – ﹤0.01% 2049
2026
Q1 		$191K Hold
42,065
– – ﹤0.01% 2027
2025
Q4 		$84.6K Hold
42,065
– – ﹤0.01% 980
2025
Q3 		$69.4K Hold
42,065
– – ﹤0.01% 1800
2025
Q2 		$39.6K Hold
42,065
– – ﹤0.01% 1739
2025
Q1 		$41.3K Hold
42,065
– – ﹤0.01% 1607
2024
Q4 		$50.1K Buy
42,065
+750
+2% +$861 ﹤0.01% 1614
2024
Q3 		$54.1K Buy
41,315
+2,010
+5% +$3.1K ﹤0.01% 1384
2024
Q2 		$60.1K Buy
39,305
+2,700
+7% +$4.67K ﹤0.01% 1357
2024
Q1 		$73.6K Buy
+36,605
New +$92.8K ﹤0.01% 1351

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Empowered Funds's IRD Position: Q2 2026 in Review

Empowered Funds held its Opus Genetics (IRD) position steady in Q2 2026 at 42,065 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2049.

Empowered Funds first reported a position in IRD in Q1 2024 and has held it in 10 quarters since. The position peaked at $191K in Q1 2026. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Empowered Funds held 42,065 shares of Opus Genetics worth $173K as of Q2 2026.
  • Empowered Funds left its Opus Genetics share count unchanged in Q2 2026.
  • Opus Genetics made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #2049 holding.
  • Empowered Funds first reported a position in Opus Genetics in Q1 2024 and has held it in 10 quarters since.
  • Empowered Funds's Opus Genetics position peaked at $191K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.